Smoking Smoking cessation Varenicline Practice nurse Intensive counselling Health care innovation
Conditions
Interventions
Participants in the intervention group recieve intensive counselling from a practice nurse in combination with 12-weeks varenicline. The intensive counselling consists of three individual face-to-face
Sponsors
D. Kotz
Research Institute CAPHRI, Department of General Practice, Maastricht University
P. Debyeplein 1, 6229 HA, Maastricht
P.O. Box 616, 6200 MD Maastricht, The Netherlands
T 043-3882893
F 043-3619344
Eligibility
Inclusion criteria
Inclusion criteria: We aim to recruit those adult smokers into the trial who normally consult with their general practitioner in primary care.
Exclusion criteria
Exclusion criteria: Participants are excluded from the study when they: 1. Do not smoke daily; 2. Are younger than 18 years; 3. Are unable to understand Dutch sufficiently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prolonged smoking abstinence from week 9 to week 26. Smoking abstinence will be validated by measuring exhaled carbon monoxide (CO) in all self-reported non-smokers. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome parameters are: 1. Cost-effectiveness of the two smoking cessation treatments, expressed as the intervention costs per quitter; 2. Compliance with varenicline in both treatment groups. | — |
Contacts
Public ContactC. Rossem, van
P.O. Box 616
Outcome results
None listed